New Clot-Busting device could change stroke care

NCT ID NCT06733246

Recruiting now Disease control Sponsor: Ceretrieve Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called Ceretrieve that is designed to remove blood clots from brain arteries in people having a severe stroke. About 132 participants will be treated within 24 hours of symptoms starting. The goal is to see if the device can safely restore blood flow and improve outcomes compared to existing devices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ceretrieve neuro-thrombectomy aspiration catheter (a device to remove blood clots from brain arteries)
What this could lead to: If successful, this device could offer a safe and effective way to restore blood flow in stroke patients, potentially reducing disability and improving recovery.
What could go wrong: This is an early-stage study with only 132 participants, and it compares results to past studies rather than a direct comparison group. There is a risk of bleeding in the brain or the device not working as well as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE

Contacts and locations

Locations

Heidelberg University Hospital
RECRUITING

Heidelberg, 69120, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.